We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories

By LabMedica International staff writers
Posted on 23 Jan 2024
Print article
Image: The ‘Sustainability in the Laboratory’ conference takes place on February 8 at the Medlab Middle East Congress (Photo courtesy of Informa Markets)
Image: The ‘Sustainability in the Laboratory’ conference takes place on February 8 at the Medlab Middle East Congress (Photo courtesy of Informa Markets)

Laboratories, known for their high energy usage, typically consume tenfold more power compared to commercial office spaces. This significant consumption underscores the importance of sustainability, a key focus at the upcoming 'Sustainability in the Lab' conference during Medlab Middle East 2024. Organized by Informa Markets Healthcare (London, UK), Medlab Middle is the largest medical laboratory exhibition in the region. The conference will spotlight the need for environmentally responsible practices in the healthcare sector, with leading experts scheduled to speak at the event.

Laboratories, well known for their resource-heavy operations, use significantly more energy and water than standard commercial offices – up to ten and four times more, respectively. Additionally, labs contribute to environmental strain by generating about 5.5 million metric tons of plastic waste yearly. Recognizing these challenges, many labs and pharmaceutical companies are proactively adopting measures to reduce their environmental footprint. The ‘Sustainability in the Laboratory’ conference at Medlab Middle East aims to bring this critical issue to the forefront. Scheduled for 8 February at the Medlab Middle East Congress, this CME Accredited event will convene experts from the UAE, US, UK, and Germany. These professionals will discuss their experiences and strategies for fostering eco-friendly initiatives in labs, enlightening attendees on sustainable practices that not only enhance operational efficiency but also mitigate environmental impact. Implementing these practices can lead to significant gains, including waste reduction and increased productivity.

Despite the lack of formal guidelines, laboratories can still make impactful changes, such as switching off idle lights and equipment and transitioning to energy-efficient LED lighting. Regular maintenance of equipment, using taps over pure water, and proper waste segregation are vital steps. The heavy reliance of labs on plastic items, like gloves, tubes, and single-use pipette tips, makes plastic recycling and reuse programs crucial for waste reduction. Additionally, laboratories can adopt ACT labels – which are akin to eco-nutrition labels for lab products – that outline the Accountability, Consistency, and Transparency in production, energy and water consumption, and end-of-life disposal for laboratory items.

Dr. Nehmat El Banna, Clinical Pathology Specialist and CEO of Freiburg Medical (Dubai, UAE), who will be speaking at the ‘Sustainability in the Laboratory’ conference believes that the topic is a crucial part of the healthcare system in general. Since the last five years, Freiburg Medical has continued to implement sustainable practices across its facility in the UAE such as the use of energy-efficient LED lighting, reduction of water usage, and utilization of instruments that are more environmentally friendly. In addition, the company works closely with its suppliers to ensure the adoption of sustainable practices.

“Laboratories are a significant player in the healthcare industry and are known to be the highest users of energy in the sector,” said Dr. Nehmat El Banna. “Climate change has a direct consequence on human health. There will be higher temperatures, more adverse weather events, and poorer air quality which leads to more illnesses, and infectious diseases will spread more easily. All of this will place a greater burden on the healthcare industry. While climate change is a complex issue with many contributing factors, the health of future generations is of paramount importance to us as a sector. We must, therefore, address the environmental footprint of laboratories and take action to mitigate the effects of our operations.”

“As the region’s largest medical laboratory exhibition and congress, sustainability has become a paramount focus for Medlab Middle East,” added Tom Coleman, Exhibition Director, Informa Markets Healthcare, who agrees that even small initiatives can make a difference. “Even small conservation efforts can lead to significant environmental and cost benefits for laboratories, this is why laboratory sustainability is becoming a top priority.”

Related Links:
Informa Markets Healthcare
Freiburg Medical

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Rickettsia Conorii Assay
RICKETTSIA CONORII ELISA

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.